Submission for OMB Review; Comment Request; the Multi-Ethnic Study of Atherosclerosis (MESA) Event Surveillance, 60863 [E7-21103]

Download as PDF 60863 Federal Register / Vol. 72, No. 207 / Friday, October 26, 2007 / Notices Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: October 22, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–21122 Filed 10–25–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; Comment Request; the Multi-Ethnic Study of Atherosclerosis (MESA) Event Surveillance Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval the information collection listed below. This proposed information collection was previously published in the Federal Register on August 21, 2007, pages 46640–46641, and allowed 60 days for public comment. No comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Proposed Collection: Title: The MultiEthnic Study of Atherosclerosis (MESA) Event Surveillance. Type of Information Collection Request: Renewal (OMB No. 0925–0493). Need and Use of Information Collection: This project identifies and quantifies factors associated with the presence and progression of subclinical cardiovascular disease (CVD)—that is, atherosclerosis and other forms of CVD that have not produced signs and symptoms. The findings provide important information on subclinical CVD in individuals of different ethnic backgrounds and provide information for studies on new interventions to prevent CVD. The aspects of the study that concern direct participant evaluation received a clinical exemption from OMB clearance (CE–99–11–08) in April 2000. OMB clearance is being sought for the contact of physicians and participant proxies to obtain information about clinical CVD events that participants experience during the follow-up period. Frequency of Response: The participants will be contacted annually. Affected Public: Individuals or households; Businesses or other for profit; Small businesses or organizations. Type of Respondents: Individuals or households; physicians. The annual reporting burden is as follows: Estimated Number of Respondents: 550; Estimated Number of Responses per Respondent: 1.0; Average Burden Hours Per Response: .2; and Estimated Total Annual Burden Hours Requested: 36.7. The annualized cost to respondents is estimated at $5,595, assuming respondents time at the rate of $18.65 per hour and physician time at the rate of $75 per hour. There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. ESTIMATES OF HOUR BURDEN Number of respondents Type of respondent Frequency of response Average time per response (hours) Annual hour burden 250 300 1 1 0.20 0.20 16.7 20 Total ........................................................................................................ rmajette on PROD1PC64 with NOTICES Physicians ...................................................................................................... Proxies ........................................................................................................... 550 1 0.20 36.7 Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding VerDate Aug<31>2005 15:23 Oct 25, 2007 Jkt 214001 the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Jean Olson, Epidemiology Branch, Division of Prevention and Population Sciences, NHLBI, NIH, II Rockledge Centre, 6701 Rockledge Drive, Suite 10018, MSC # 7936, Bethesda, MD, 20892–7936, or call 301–435–0397 (non-toll-free number), or e-mail your request, including your address to: OlsonJ@nhlbi.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 received within 30-days of the date of this publication. Dated: October 16, 2007. Mike Lauer, Director, Division of Prevention and Population Sciences, NHLBI, National Institutes of Health. Dated: October 18, 2007. Suzanne Freeman, OMB Clearance Officer, NHLBI, National Institutes of Health. [FR Doc. E7–21103 Filed 10–25–07; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. AGENCY: E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 72, Number 207 (Friday, October 26, 2007)]
[Notices]
[Page 60863]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21103]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Comment Request; the Multi-Ethnic 
Study of Atherosclerosis (MESA) Event Surveillance

    Summary: Under the provisions of Section 3507(a)(1)(D) of the 
Paperwork Reduction Act of 1995, the National Heart, Lung, and Blood 
Institute (NHLBI), the National Institutes of Health (NIH) has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register on August 21, 2007, pages 46640-46641, and allowed 60 days for 
public comment. No comments were received. The purpose of this notice 
is to allow an additional 30 days for public comment. The National 
Institutes of Health may not conduct or sponsor, and the respondent is 
not required to respond to, an information collection that has been 
extended, revised, or implemented on or after October 1, 1995, unless 
it displays a currently valid OMB control number.
    Proposed Collection: Title: The Multi-Ethnic Study of 
Atherosclerosis (MESA) Event Surveillance. Type of Information 
Collection Request: Renewal (OMB No. 0925-0493). Need and Use of 
Information Collection: This project identifies and quantifies factors 
associated with the presence and progression of subclinical 
cardiovascular disease (CVD)--that is, atherosclerosis and other forms 
of CVD that have not produced signs and symptoms. The findings provide 
important information on subclinical CVD in individuals of different 
ethnic backgrounds and provide information for studies on new 
interventions to prevent CVD. The aspects of the study that concern 
direct participant evaluation received a clinical exemption from OMB 
clearance (CE-99-11-08) in April 2000. OMB clearance is being sought 
for the contact of physicians and participant proxies to obtain 
information about clinical CVD events that participants experience 
during the follow-up period. Frequency of Response: The participants 
will be contacted annually. Affected Public: Individuals or households; 
Businesses or other for profit; Small businesses or organizations. Type 
of Respondents: Individuals or households; physicians. The annual 
reporting burden is as follows: Estimated Number of Respondents: 550; 
Estimated Number of Responses per Respondent: 1.0; Average Burden Hours 
Per Response: .2; and Estimated Total Annual Burden Hours Requested: 
36.7. The annualized cost to respondents is estimated at $5,595, 
assuming respondents time at the rate of $18.65 per hour and physician 
time at the rate of $75 per hour. There are no Capital Costs to report. 
There are no Operating or Maintenance Costs to report.

                                            Estimates of Hour Burden
----------------------------------------------------------------------------------------------------------------
                                                                                  Average time
               Type of respondent                   Number of     Frequency of    per response     Annual hour
                                                   respondents      response         (hours)          burden
----------------------------------------------------------------------------------------------------------------
Physicians.....................................             250               1            0.20             16.7
Proxies........................................             300               1            0.20             20
                                                ----------------------------------------------------------------
    Total......................................             550               1            0.20             36.7
----------------------------------------------------------------------------------------------------------------

    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies should address one or more of the 
following points: (1) Evaluate whether the proposed collection of 
information is necessary for the proper performance of the function of 
the agency, including whether the information will have practical 
utility; (2) Evaluate the accuracy of the agency's estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used; (3) Enhance the 
quality, utility, and clarity of the information to be collected; and 
(4) Minimize the burden of the collection of information on those who 
are to respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, New Executive Office Building, Room 10235, Washington, DC 
20503, Attention: Desk Officer for NIH. To request more information on 
the proposed project or to obtain a copy of the data collection plans 
and instruments, contact: Dr. Jean Olson, Epidemiology Branch, Division 
of Prevention and Population Sciences, NHLBI, NIH, II Rockledge Centre, 
6701 Rockledge Drive, Suite 10018, MSC  7936, Bethesda, MD, 
20892-7936, or call 301-435-0397 (non-toll-free number), or e-mail your 
request, including your address to: OlsonJ@nhlbi.nih.gov.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

    Dated: October 16, 2007.
Mike Lauer,
Director, Division of Prevention and Population Sciences, NHLBI, 
National Institutes of Health.
    Dated: October 18, 2007.
Suzanne Freeman,
OMB Clearance Officer, NHLBI, National Institutes of Health.
 [FR Doc. E7-21103 Filed 10-25-07; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.